Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1).
about
Stabilization and activation of p53 by the coactivator protein TAFII31Novel ATPase of SNF2-like protein family interacts with androgen receptor and modulates androgen-dependent transcriptionTranscription factor AP-2 interacts with the SUMO-conjugating enzyme UBC9 and is sumolated in vivoSUMO modification of the Ets-related transcription factor ERM inhibits its transcriptional activityNegative modulation of androgen receptor transcriptional activity by DaxxSUMOylation of human peroxisome proliferator-activated receptor alpha inhibits its trans-activity through the recruitment of the nuclear corepressor NCoRInhibition of androgen receptor activity by histone deacetylase 4 through receptor SUMOylationSmall carboxyl-terminal domain phosphatase 2 attenuates androgen-dependent transcriptionSupervillin associates with androgen receptor and modulates its transcriptional activityMembers of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activityModification with SUMO. A role in transcriptional regulationModification of the human thymine-DNA glycosylase by ubiquitin-like proteins facilitates enzymatic turnoverTranscription factor Sp3 is silenced through SUMO modification by PIAS1The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylaseStructure and function of steroid receptor AF1 transactivation domains: induction of active conformationsA domain unique to plant RanGAP is responsible for its targeting to the plant nuclear rimRole for SUMO modification in facilitating transcriptional repression by BKLF.SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1Repression of PML nuclear body-associated transcription by oxidative stress-activated Bach2RSUME enhances glucocorticoid receptor SUMOylation and transcriptional activityhZimp10 is an androgen receptor co-activator and forms a complex with SUMO-1 at replication fociRole of desumoylation in the development of prostate cancerPhosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1Phosphorylation-facilitated sumoylation of MEF2C negatively regulates its transcriptional activityFunctional role of NF-IL6beta and its sumoylation and acetylation modifications in promoter activation of cyclooxygenase 2 gene.Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophyPost-translational modifications of the progesterone receptorsModulation of the transcriptional activity of peroxisome proliferator-activated receptor gamma by protein-protein interactions and post-translational modificationsRegulation of heat shock transcription factor 1 by stress-induced SUMO-1 modificationTAF1 differentially enhances androgen receptor transcriptional activity via its N-terminal kinase and ubiquitin-activating and -conjugating domainsA synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3Transforming growth factor-beta-mediated signaling via the p38 MAP kinase pathway activates Smad-dependent transcription through SUMO-1 modification of Smad4Ubc9 is a novel modulator of the induction properties of glucocorticoid receptorsTranscriptional activity of CCAAT/enhancer-binding proteins is controlled by a conserved inhibitory domain that is a target for sumoylationPIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcriptionAn androgen receptor NH2-terminal conserved motif interacts with the COOH terminus of the Hsp70-interacting protein (CHIP)SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells.Small ubiquitin-like modifier (SUMO) modification of the androgen receptor attenuates polyglutamine-mediated aggregationDisrupting SUMOylation enhances transcriptional function and ameliorates polyglutamine androgen receptor-mediated disease.Dynamic SUMO modification regulates mitotic chromosome assembly and cell cycle progression in Caenorhabditis elegans.
P2860
Q24291008-47B22B88-6F77-49BF-9058-6B4C47C0009DQ24299539-93AD3646-7F7B-49B7-B84A-9EBB910E323CQ24299957-0D9EFED1-1F3D-4C1A-8983-DDF1E1BFCBF2Q24300888-227CA2D2-A44C-4482-887D-28D260317671Q24318233-6D90813B-DEEB-4B5F-BCC8-E25B05006612Q24324236-DDD698F0-0CF8-45A1-BE67-414F65CCFF11Q24337533-BB5ECDB0-F1D3-4F78-A61D-02BF93B95CF1Q24337882-C6EC4354-65C9-4C5A-82C7-2B653F4A36FDQ24530343-9162A515-9250-4B98-B171-5222EE69F22EQ24531180-C5BD0D3E-449D-4F34-B3A3-B5D37677E0B3Q24534589-34AF555B-F2DD-4A1B-B1E8-743EC6F58642Q24534803-154BADE7-298E-49FE-899A-7A8E951EA641Q24534887-4F5BC903-7FCE-4991-AC20-0F1C854E0B6BQ24534918-96A4480B-CB22-462E-B3D0-3634BF735C23Q24537137-0C677881-D6F0-4A6C-85F5-37E9163DB8DCQ24555045-5D5BA601-BB64-43C6-B9D5-74E221C9C63AQ24556900-9CC8FE5A-E3B1-40AE-BD46-F0CA6B047765Q24563640-070915EE-F7DF-4CA8-99DA-FB390BCD36BBQ24602452-FE6F1873-767A-41C6-8B2E-93A30A34B1B1Q24629429-4A74B855-1175-4D25-AAB9-519EFDB70408Q24644349-37CF6BF3-4188-4A40-B107-460EF5B67805Q24676101-197C6BA0-8C49-4774-ACA9-20B4A5474D78Q24685095-8C9D0BB8-824E-4943-9783-1692A3365934Q25256622-D68466A9-D081-4AB7-99E8-13E8FF69AA91Q25257455-A7EE7178-E3AE-4CE2-838C-49432F392A64Q27007098-ACFFB1CA-FAB0-4C8D-A71F-5E0A12AC8D11Q27010251-A7D019B6-2BF4-4AC6-92FE-0B383497612EQ27015807-651F6F9A-70BC-46E6-AEFD-B519741CC279Q28116002-2772EEA3-8BB8-45AA-9C70-86BC6110D044Q28119073-A3AF84C0-498B-4826-8987-D6FD2BCE5EAFQ28201630-EA56DAA5-44E7-46BD-92A3-6E50A403DAA2Q28205342-67FBDA15-49FE-4F0D-9D36-569EA712EFECQ28216743-9150FEB6-26E7-4B0B-A15E-B741BFBA1BF7Q28216841-1FEF0724-4F78-4190-ACCF-B9F2542C003CQ28217862-82BC9F90-3C0A-451C-A24F-316844C13C0FQ28258333-A506A467-1FD9-4D8B-8EE3-FC47B61AD807Q30352713-EC749D72-2B25-46E5-8DA9-6A69927C2181Q30377831-1CFB1A8C-2635-4EE4-A8EA-7BF80AD3C735Q30405382-4F20D40E-1C00-4919-BA37-56FAA6781478Q30608755-561BF3A0-A2F4-4292-A20F-588C33D5CEE3
P2860
Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1).
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Covalent modification of the a ...... itin-like modifier 1 (SUMO-1).
@ast
Covalent modification of the a ...... itin-like modifier 1 (SUMO-1).
@en
type
label
Covalent modification of the a ...... itin-like modifier 1 (SUMO-1).
@ast
Covalent modification of the a ...... itin-like modifier 1 (SUMO-1).
@en
prefLabel
Covalent modification of the a ...... itin-like modifier 1 (SUMO-1).
@ast
Covalent modification of the a ...... itin-like modifier 1 (SUMO-1).
@en
P2093
P2860
P356
P1476
Covalent modification of the a ...... itin-like modifier 1 (SUMO-1).
@en
P2093
P2860
P304
14145-14150
P356
10.1073/PNAS.97.26.14145
P407
P577
2000-12-01T00:00:00Z